NeuroOne Medical Technologies Corporation
NMTC
$3.39
-$0.07-2.02%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 120.89% | 103.77% | 250.36% | 69.00% | 54.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 120.89% | 103.77% | 250.36% | 69.00% | 54.53% |
| Cost of Revenue | 25.59% | 17.67% | 20.18% | -7.83% | -15.80% |
| Gross Profit | 267.86% | 228.19% | 179.24% | 73.36% | 64.93% |
| SG&A Expenses | -6.53% | -7.01% | -6.54% | -2.48% | 1.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 200.00% | 200.00% | -- | -- | -- |
| Total Operating Expenses | 60.37% | 54.46% | 6.42% | -23.87% | -26.02% |
| Operating Income | -7.39% | -12.67% | 64.44% | 53.64% | 49.20% |
| Income Before Tax | -0.61% | 5.00% | 70.73% | 55.90% | 48.43% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.61% | 5.00% | 70.73% | 55.90% | 48.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.61% | 5.00% | 70.73% | 55.90% | 48.43% |
| EBIT | -7.39% | -12.67% | 64.44% | 53.64% | 49.20% |
| EBITDA | -7.72% | -13.02% | 65.94% | 54.87% | 50.27% |
| EPS Basic | 41.94% | 38.02% | 83.09% | 67.78% | 61.09% |
| Normalized Basic EPS | 51.46% | 39.57% | 81.68% | 62.20% | 57.56% |
| EPS Diluted | 41.10% | 37.35% | 83.04% | 67.75% | 61.07% |
| Normalized Diluted EPS | 51.47% | 39.58% | 81.67% | 62.19% | 57.56% |
| Average Basic Shares Outstanding | 67.83% | 58.11% | 50.01% | 41.04% | 32.72% |
| Average Diluted Shares Outstanding | 67.77% | 58.05% | 50.05% | 41.08% | 32.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |